Through further comparison between the combination therapy group and MH group, it was found that the expression levels of GFAP and VEGF increased, and the mNSS scores and the percentage of the infarct area decreased at early stage of cerebral ischemia, indicating that the combination therapy had a better performance than MH alone. The gene discussed is VEGFA; the disease is Cerebral ischemia.